10-97572822-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001346793.2(ANKRD2):c.34C>A(p.Gln12Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000619 in 1,566,654 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001346793.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD2 | NM_001346793.2 | c.34C>A | p.Gln12Lys | missense_variant | 1/9 | ENST00000370655.6 | NP_001333722.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD2 | ENST00000370655.6 | c.34C>A | p.Gln12Lys | missense_variant | 1/9 | 1 | NM_001346793.2 | ENSP00000359689 | ||
ANKRD2 | ENST00000307518.9 | c.115C>A | p.Gln39Lys | missense_variant | 1/9 | 1 | ENSP00000306163 | P1 | ||
ANKRD2 | ENST00000298808.9 | c.115C>A | p.Gln39Lys | missense_variant | 1/8 | 1 | ENSP00000298808 | |||
ANKRD2 | ENST00000455090.1 | c.34C>A | p.Gln12Lys | missense_variant | 1/8 | 1 | ENSP00000403114 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152214Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000174 AC: 3AN: 172190Hom.: 0 AF XY: 0.0000109 AC XY: 1AN XY: 91472
GnomAD4 exome AF: 0.0000672 AC: 95AN: 1414324Hom.: 0 Cov.: 32 AF XY: 0.0000572 AC XY: 40AN XY: 699106
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152330Hom.: 0 Cov.: 33 AF XY: 0.0000268 AC XY: 2AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2023 | The c.115C>A (p.Q39K) alteration is located in exon 1 (coding exon 1) of the ANKRD2 gene. This alteration results from a C to A substitution at nucleotide position 115, causing the glutamine (Q) at amino acid position 39 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at